Lower-middle income (World Bank) vs Turkmenistan: HPV immunization coverage estimates among primary target cohort (9-14)
Lower-middle income (World Bank)
27.0%
in 2025
Turkmenistan
95.0%
in 2025
Lower-middle income (World Bank) rank
8th
Turkmenistan rank
9th
HPV immunization coverage estimates among primary target cohort (9-14) over time
- Lower-middle income (World Bank)
- Turkmenistan
How they compare
Turkmenistan currently reports 95.0% against 27.0% in Lower-middle income (World Bank), a difference of 68.0%.
That makes Turkmenistan's figure about 3.5 times Lower-middle income (World Bank)'s.
Across all 10 years both countries report, Turkmenistan has been ahead every year.
Lower-middle income (World Bank) ranks 8th and Turkmenistan ranks 9th of 11 groups.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.2% | 95.8% | 93.5% | Turkmenistan |
| 2020s | 14.3% | 98.0% | 83.7% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv immunization coverage estimates among primary target cohort (9-14), Lower-middle income (World Bank) or Turkmenistan?
- Turkmenistan, at 95.0% against 27.0% in Lower-middle income (World Bank) as of 2025.
- What is the difference in hpv immunization coverage estimates among primary target cohort (9-14) between Lower-middle income (World Bank) and Turkmenistan?
- 68.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Turkmenistan?
- 10 years are reported by both, from 2016 to 2025.
- How do Lower-middle income (World Bank) and Turkmenistan rank globally for hpv immunization coverage estimates among primary target cohort (9-14)?
- Lower-middle income (World Bank) ranks 8th and Turkmenistan ranks 9th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.